Prospective Multi-Center Office-Based Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception (BLOC) (Protocol # CP-100-007)

Study Details

Prospective, multi-center, international, non-randomized, two-arm study of subjects undergoing either FemBloc or laparoscopic bilateral tubal sterilization (Control). The FemBloc group total study duration will be approximately 65 months. The laparoscopic tubal sterilization (Control) group total study duration will be approximately 62 months.

Learn More

ClinicalTrials.gov NCT number
NCT03433911

Principal Investigators

  • Scott Chudnoff, MD
Sponsor(s)
Femasys Inc.
Contact
Maureen Magnani, BSN, RN at 203-358-8879
or officeofresearch@stamhealth.org